S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
S&P 500   4,953.71 (-0.44%)
DOW   38,428.16 (-0.35%)
QQQ   423.52 (-0.89%)
AAPL   181.14 (-0.23%)
MSFT   399.39 (-0.84%)
META   467.59 (-0.78%)
GOOGL   142.23 (+0.79%)
AMZN   168.30 (+0.73%)
TSLA   194.20 (+0.23%)
NVDA   674.39 (-2.90%)
NIO   6.09 (+2.18%)
AMD   163.60 (-1.26%)
BABA   75.62 (+3.39%)
T   16.92 (+0.06%)
F   12.10 (-1.22%)
MU   80.45 (-0.32%)
CGC   3.40 (-3.95%)
GE   148.35 (-0.18%)
DIS   107.66 (-1.63%)
AMC   4.55 (-2.36%)
PFE   27.45 (-0.51%)
PYPL   57.51 (-1.91%)
XOM   104.89 (+2.08%)
NYSE:WAT

Waters (WAT) Stock Price, News & Analysis

$326.99
+3.04 (+0.94%)
(As of 02:21 PM ET)
Today's Range
$321.27
$327.82
50-Day Range
$302.51
$333.01
52-Week Range
$231.90
$335.40
Volume
113,593 shs
Average Volume
420,366 shs
Market Capitalization
$19.33 billion
P/E Ratio
30.14
Dividend Yield
N/A
Price Target
$293.50

Waters MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.86 Rating Score
Upside/​Downside
8.7% Downside
$293.50 Price Target
Short Interest
Bearish
7.05% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.66
Upright™ Environmental Score
News Sentiment
-0.06mentions of Waters in the last 14 days
Based on 56 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.77%
From $11.89 to $13.17 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.36 out of 5 stars

Medical Sector

1029th out of 1,856 stocks

Analytical Instruments Industry

27th out of 56 stocks


WAT stock logo

About Waters Stock (NYSE:WAT)

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

WAT Stock Price History

WAT Stock News Headlines

An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Murkier waters for the Fed
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
See More Headlines
Receive WAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Waters and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/06/2024
Today
2/21/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
94184810
Employees
8,200
Year Founded
1958

Price Target and Rating

Average Stock Price Target
$293.50
High Stock Price Target
$330.00
Low Stock Price Target
$250.00
Potential Upside/Downside
-9.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Net Income
$642.23 million
Pretax Margin
24.90%

Debt

Sales & Book Value

Annual Sales
$2.96 billion
Cash Flow
$14.53 per share
Book Value
$19.45 per share

Miscellaneous

Free Float
58,672,000
Market Cap
$19.15 billion
Optionable
Optionable
Beta
0.92

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Udit Batra Ph.D. (Age 53)
    President, CEO & Director
    Comp: $3.11M
  • Mr. Amol Chaubal (Age 47)
    Senior VP & CFO
    Comp: $1.23M
  • Ms. Keeley A. Aleman (Age 47)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $897.33k
  • Ms. Jianqing Y. Bennett (Age 54)
    Senior Vice President of TA Instruments Division & Waters Clinical Business Unit
    Comp: $1.24M
  • Mr. Christos Ross
    Senior VP of Global Operations & Interim Senior VP of the Waters Division
  • Caspar Tudor
    Director of Investor Relations
  • Ms. Kristen Garvey
    Vice President of Corporate Communications
  • Dr. Belinda Gaye Hyde Ph.D. (Age 53)
    Senior Vice President of Global Human Resources
    Comp: $1.31M
  • Dr. Daniel Rush Ph.D.
    Senior Vice President of Strategy & Transformation
  • John Lynch
    Treasurer














WAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Waters stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last twelve months. There are currently 1 sell rating and 6 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" WAT shares.
View WAT analyst ratings
or view top-rated stocks.

What is Waters' stock price target for 2024?

7 equities research analysts have issued twelve-month price objectives for Waters' shares. Their WAT share price targets range from $250.00 to $330.00. On average, they expect the company's share price to reach $293.50 in the next twelve months. This suggests that the stock has a possible downside of 8.7%.
View analysts price targets for WAT
or view top-rated stocks among Wall Street analysts.

How have WAT shares performed in 2024?

Waters' stock was trading at $329.23 at the beginning of the year. Since then, WAT shares have decreased by 2.3% and is now trading at $321.51.
View the best growth stocks for 2024 here
.

When is Waters' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our WAT earnings forecast
.

How were Waters' earnings last quarter?

Waters Co. (NYSE:WAT) announced its earnings results on Tuesday, February, 6th. The medical instruments supplier reported $3.62 earnings per share for the quarter, beating analysts' consensus estimates of $3.56 by $0.06. The medical instruments supplier earned $819.50 million during the quarter, compared to the consensus estimate of $815.50 million. Waters had a trailing twelve-month return on equity of 81.30% and a net margin of 21.72%. The firm's revenue was down 4.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.84 earnings per share.
Read the conference call transcript
.

What guidance has Waters issued on next quarter's earnings?

Waters issued an update on its FY24 earnings guidance on Tuesday, February, 6th. The company provided EPS guidance of $11.75-12.05 for the period, compared to the consensus earnings per share estimate of $11.94.

What is Udit Batra's approval rating as Waters' CEO?

13 employees have rated Waters Chief Executive Officer Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among the company's employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Waters own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), RTX (RTX), CVS Health (CVS), Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Who are Waters' major shareholders?

Waters' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.56%), Massachusetts Financial Services Co. MA (5.17%), Generation Investment Management LLP (2.79%), GUARDCAP ASSET MANAGEMENT Ltd (1.86%), Nordea Investment Management AB (1.65%) and AKO Capital LLP (1.31%). Insiders that own company stock include Christopher A Kuebler, Edward Conard, Joann A Reed, Linda Baddour, Mark P Vergnano, Michael J Berendt and Thomas P Salice.
View institutional ownership trends
.

How do I buy shares of Waters?

Shares of WAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Waters have any subsidiaries?
The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions, Integrated Software Solutions Limited (UK), Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).
Read More
This page (NYSE:WAT) was last updated on 2/21/2024 by MarketBeat.com Staff